Air break during preoxygenation and risk of altitude decompression sickness.

INTRODUCTION To reduce the risk of decompression sickness (DCS), current USAF U-2 operations require a 1-h preoxygenation (PreOx). An interruption of oxygen breathing with air breathing currently requires significant extension of the PreOx time. The purpose of this study was to evaluate the relationship between air breaks during PreOx and subsequent DCS and venous gas emboli (VGE) incidence, and to determine safe air break limits for operational activities. METHODS Volunteers performed 30 min of PreOx, followed by either a 10-min, 20-min, or 60-min air break, then completed another 30 min of PreOx, and began a 4-h altitude chamber exposure to 9144 m (30,000 ft). Subjects were monitored for VGE using echocardiography. Altitude exposure was terminated if DCS symptoms developed. Control data (uninterrupted 60-min PreOx) to compare against air break data were taken from the AFRL DCS database. RESULTS At 1 h of altitude exposure, DCS rates were significantly higher in all three break in prebreathe (BiP) profiles compared to control (40%, 45%, and 47% vs. 24%). At 2 h, the 20-min and 60-min BiP DCS rates remained higher than control (70% and 69% vs. 52%), but no differences were found at 4 h. No differences in VGE rates were found between the BiP profiles and control. DISCUSSION Increased DCS risk in the BiP profiles is likely due to tissue renitrogenation during air breaks not totally compensated for by the remaining PreOx following the air breaks. Air breaks of 10 min or more occurring in the middle of 1 h of PreOx may significantly increase DCS risk during the first 2 h of exposure to 9144 m when compared to uninterrupted PreOx exposures.

[1]  H. King,et al.  Headache and altitude decompression sickness: joint pain or neurological pain? , 2005, Aviation Space and Environmental Medicine.

[2]  J. T. Webb,et al.  Altitude decompression sickness susceptibility: influence of anthropometric and physiologic variables. , 2005, Aviation, space, and environmental medicine.

[3]  J. T. Webb,et al.  Central nervous system decompression sickness and venous gas emboli in hypobaric conditions. , 2004, Aviation, space, and environmental medicine.

[4]  J. T. Webb,et al.  The risk of altitude decompression sickness at 12,000 m and the effect of ascent rate. , 2003, Aviation Space and Environmental Medicine.

[5]  J. T. Webb,et al.  Pulmonary decompression sickness at altitude: early symptoms and circulating gas emboli. , 2002, Aviation, space, and environmental medicine.

[6]  A. Pilmanis,et al.  The initial signs and symptoms of altitude decompression sickness. , 1996, Aviation, space, and environmental medicine.

[7]  J. T. Webb,et al.  Exercise-enhanced preoxygenation increases protection from decompression sickness. , 1996, Aviation, space, and environmental medicine.

[8]  J. P. Cooke Denitrogenation interruptions with air. [resulting in decompression sickness , 1976 .

[9]  M. Spencer,et al.  Decompression limits for compressed air determined by ultrasonically detected blood bubbles. , 1976, Journal of applied physiology.

[10]  J. T. Webb,et al.  Gender not a factor for altitude decompression sickness risk. , 2003, Aviation, space, and environmental medicine.

[11]  U I Balldin,et al.  Effects of ambient temperature and body position on tissue nitrogen elimination in man. , 1973, Aerospace medicine.

[12]  J. T. Webb,et al.  Altitude Decompression Sickness Between 6858 and 9144 m Following a 1h Prebreathe Dt " STF 3 EUTION STATEMENT A iypp ( , ved for Public Release , 2022 .